Researchers may have found an unconventional and novel way to detect Alzheimer’s disease before symptoms develop, using a new technology. In a study, scientists used peptoids instead of antigens to find biomarkers of early Alzheimer’s disease with 90 percent accuracy.
Blood test could detect Alzheimer’s disease before symptoms appear
by Kathleen Blanchard RN on 16. Feb, 2011 in Health News
Could eating grapes fight obesity?
by Kathleen Blanchard RN on 08. Jan, 2011 in Health News
Resveratrol is found in lab and mouse studies to stimulate an important fat hormone. The findings could mean new treatment for obesity, diabetes and other diseases.
Beetroot Juice Health Benefits not Just for Athletes
by Kathleen Blanchard RN on 18. Dec, 2010 in Health News
Beetroot juice has been shown to increase physical performance. Researchers found drinking the juice reduces the amount of effort needed to walk. Their findings suggest drinking beetroot juice could be a dietary intervention that could help elders live more active lives.
Bedbugs Explained by Allergy Expert
by Kathleen Blanchard RN on 21. Nov, 2010 in Health News
Dr. Jospeh Leija, an allergist at Gottlieb Memorial Hospital, part of Loyola University Health System explains how bedbugs travel, find their prey, and provides tips to keep bedbugs away.
Researchers Learn how the Liver Regenerates
by Kathleen Blanchard RN on 12. Nov, 2010 in Health News
Researchers have discovered how the liver is able to regenerate. The findings are important for patients who develop hepatitis and cirrhosis of the liver. Some mysteries still remain, but the study opens new doors for treating liver damage.
Metformin could Protect Smokers from Lung Cancer
by Kathleen Blanchard RN on 06. Nov, 2010 in Health News
Research show metformin, a drug used to treat type 2 diabetes, could protect smokers from lung cancer. The unique properties of the drug inhibits pathways that stimulate lung cancer tumor growth and metastasis.
Potent Hepatitis C Drug Passes First Clinical Trial
by Kathleen Blanchard RN on 06. Sep, 2010 in Health News
A new drug has passed Phase 1a clinical trials for treatment of Hepatitis C. INX-189 is a potent drug that killed 90 percent of the Hepatitis C virus in a 2008 study. The drug is being studied in the United States and could offer hope to 170 million people worldwide diagnosed with the disease.

Back to Top